![Daniel Dolan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Daniel Dolan worked as Vice President of Financial Planning & Analysis at Radius Health, Inc. from 2020 to 2021.
Prior to that, he worked at Shire Plc as Vice President of Finance Global Product Strategy from 2016 to 2017.
Currently, he is the Chief Financial Officer at Nabriva Therapeutics Plc, a position he started in 2021 and will hold until 2023.
Dolan received his undergraduate degree and MBA from Widener University.
Anciens postes connus de Daniel Dolan
| Sociétés | Poste | Fin |
|---|---|---|
| NABRIVA THERAPEUTICS PLC | Directeur Financier/CFO | 30/06/2023 |
| RADIUS HEALTH, INC. | Directeur Financier/CFO | 15/12/2020 |
| SHIRE | Corporate Officer/Principal | 01/07/2017 |
Formation de Daniel Dolan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Develops and markets medicines for patients with rare diseases | Health Technology |
Widener University
 Widener University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nabriva Therapeutics Plc
 Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents | Health Technology |
